SSRIs/SNRI/Triptan and Serotonin Syndrome [issued 7/2006]
A life-threatening condition called serotonin
syndrome can happen when medicines called selective serotonin/norepinephrine
reuptake inhibitors (SNRIs), such as Cymbalta, and medicines used
to treat migraine headaches known as 5-hydroxytryptamine
receptor agonists (triptans), are used together... More about this FDA Alert
This information reflects FDA’s
current analysis of data available to FDA concerning these drugs.
FDA intends to update this sheet when additional information or
analyses become available.
For complete, up-to-date safety information by the FDA, see MedWatch